4.7 Article

Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis

Journal

DRUG DELIVERY
Volume 29, Issue 1, Pages 2723-2733

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10717544.2022.2112115

Keywords

Periplaneta americana; ulcerative colitis; oral drug administration; Eudragit S100; microparticles; polypeptide

Funding

  1. department of science & technology of Liaoning province [2021-BS-131]

Ask authors/readers for more resources

In this study, a pH-dependent drug delivery method using polymer cellulose acetate was developed to deliver active components to the inflamed colon for the treatment of ulcerative colitis, avoiding degradation in the stomach.
Ulcerative colitis (UC) is a chronic disease, which can result the inflammation of the rectum, mucosa of the colon, and submucosa. The active component such as polypeptide in Periplaneta americana, which is one of the most common insects in the nature, can be extracted to treat UC. However, the active components in Periplaneta americana extract (PAE) can be degraded in the stomach due to its extreme acidic environment and enzyme. In this study, we developed a pH-dependent drug delivery method using polymer cellulose acetate (Eudragit S100) as a carrier to deliver high concentration PAE to inflamed colon. Both in vitro and in vivo results showed the PAE-Eudragit-S100 could treat UC through delivering active drug components to colon without degradation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available